Refine
Has Fulltext
- yes (12)
Is part of the Bibliography
- yes (12)
Year of publication
Document Type
- Journal article (11)
- Doctoral Thesis (1)
Keywords
- Medizin (2)
- antibodies (2)
- hippocampus (2)
- 65-kda isoform (1)
- CLN3 (1)
- Cytokines (1)
- Dorsal root ganglion (1)
- Glutamic-acid decarboxylase anxiety (1)
- IVIg (1)
- NMO-IGG (1)
- NMOSD (1)
- Pain (1)
- Schlaganfall (1)
- Schmerz (1)
- Spinalganglion (1)
- TNF alpha (1)
- Zytokine (1)
- amygdala (1)
- anti-aquaporin-4 antibody (1)
- anxiety (1)
- aquaporin 4 (1)
- aquaporin-4 autoantibodies (1)
- artery occlusion (1)
- autoantibodies (1)
- autoantibody (1)
- behavioral disorders (1)
- blastocysts (1)
- brain (1)
- brain development (1)
- cerebrospinal-fluid (1)
- derivation (1)
- differentiation (1)
- disorder (1)
- endotheliopathy (1)
- extensiv transverse myelitis (1)
- fear memory (1)
- glycine receptor autoantibodies (1)
- hearing loss (1)
- immune-response (1)
- immunoglobulin-G (1)
- in-vitro (1)
- intractable hiccup (1)
- intrathecal application (1)
- lines (1)
- methylation (1)
- mice (1)
- microangiopathy (1)
- mouse model (1)
- multiple sclerosis (1)
- multiple-sclerosis (1)
- mutation (1)
- myasthenia gravis (1)
- neurology (1)
- neurons (1)
- optical coherence tomography (1)
- pluripotent (1)
- presynaptic inhibition (1)
- retinocochleocerebral (1)
- retrograde Marker (1)
- retrograde tracers (1)
- specification (1)
- spinal-cord-injury (1)
- spontaneous network activity (1)
- synaptic transmission (1)
- transient bursting (1)
- vasculopathy (1)
Institute
EU-Project number / Contract (GA) number
- 222943 (1)
Susac syndrome, a rare but probably underdiagnosed combination of encephalopathy, hearing loss, and visual deficits due to branch retinal artery occlusion of unknown aetiology has to be considered as differential diagnosis in various conditions. Particularly, differentiation from multiple sclerosis is often challenging since both clinical presentation and diagnostic findings may overlap. Optical coherence tomography is a powerful and easy to perform diagnostic tool to analyse the morphological integrity of retinal structures and is increasingly established to depict characteristic patterns of retinal pathology in multiple sclerosis. Against this background we hypothesised that differential patterns of retinal pathology facilitate a reliable differentiation between Susac syndrome and multiple sclerosis. In this multicenter cross-sectional observational study optical coherence tomography was performed in nine patients with a definite diagnosis of Susac syndrome. Data were compared with age-, sex-, and disease duration-matched relapsing remitting multiple sclerosis patients with and without a history of optic neuritis, and with healthy controls. Using generalised estimating equation models, Susac patients showed a significant reduction in either or both retinal nerve fibre layer thickness and total macular volume in comparison to both healthy controls and relapsing remitting multiple sclerosis patients. However, in contrast to the multiple sclerosis patients this reduction was not distributed over the entire scanning area but showed a distinct sectorial loss especially in the macular measurements. We therefore conclude that patients with Susac syndrome show distinct abnormalities in optical coherence tomography in comparison to multiple sclerosis patients. These findings recommend optical coherence tomography as a promising tool for differentiating Susac syndrome from MS.
Ischemic stroke is the second leading cause of death worldwide. Only one moderately effective therapy exists, albeit with contraindications that exclude 90% of the patients. This medical need contrasts with a high failure rate of more than 1,000 pre-clinical drug candidates for stroke therapies. Thus, there is a need for translatable mechanisms of neuroprotection and more rigid thresholds of relevance in pre-clinical stroke models. One such candidate mechanism is oxidative stress. However, antioxidant approaches have failed in clinical trials, and the significant sources of oxidative stress in stroke are unknown. We here identify NADPH oxidase type 4 (NOX4) as a major source of oxidative stress and an effective therapeutic target in acute stroke. Upon ischemia, NOX4 was induced in human and mouse brain. Mice deficient in NOX4 (Nox42/2) of either sex, but not those deficient for NOX1 or NOX2, were largely protected from oxidative stress, blood-brain-barrier leakage, and neuronal apoptosis, after both transient and permanent cerebral ischemia. This effect was independent of age, as elderly mice were equally protected. Restoration of oxidative stress reversed the stroke-protective phenotype in Nox42/2 mice. Application of the only validated low-molecular-weight pharmacological NADPH oxidase inhibitor, VAS2870, several hours after ischemia was as protective as deleting NOX4. The extent of neuroprotection was exceptional, resulting in significantly improved long-term neurological functions and reduced mortality. NOX4 therefore represents a major source of oxidative stress and novel class of drug target for stroke therapy.